Barry Plant MD, FRCPI, MFSEM

Dr. Barry J. Plant, MD, FRCPI, MFSEM is a Consultant Respiratory Physician at the University College Cork. A University College Cork Medical Graduate (Honours), he dual trained in Respiratory and General Medicine in accordance with the Royal College of Physicians of Ireland and subsequently undertook a Fellowship in Pulmonary and Critical Medicine at the University of Washington, Seattle with a special interest in CF, where he remained until securing his current post in 2007. He is the current Chairperson for the Royal College of Physicians of Ireland’s Clinical Advisory Group (CAG) for Cystic Fibrosis, a lead author of “Cystic Fibrosis: A Model of Care for Ireland” NCP CF 2019, and the Adult Chairperson for the CF Covid NCP CF working group 2020. Professor Plant’s research group focuses on translational medicine. In response to the Covid-19 pandemic, he and his research group have established the TeCC (Telemedicine, Cystic Fibrosis, Corona-virus) study to enhance CF care. He has previously received research grant support from many funding agencies including coordinating an FP7 award from the EU commission which completed a randomized multi-center control trial of microbiome-derived antimicrobial treatments versus current empirical therapy. Equally, his research group has significant clinical and research experience in the area of CFTR modulation and Aging in CF. His group actively participates in many CF clinical trials and he has been a PI on ‘real-world’ implications of new inhaled antibiotic delivery systems, and multicentre groups. Recently Professor Plant was a Global PI on a triple therapy CFTR modulator in CF. He has been an invited speaker at a number of meetings including ATS, ERS, ECFC, Australasian CF Society, and an FDA meeting.